Analysis reveals enhanced T stem cell characteristics in peripheral blood of patients treated with IL-12 immunocytokine therapy.
Supplementary Figure 2. Gating strategy of human TSCM. (A) Gating of human CD8+ TSCM cells in peripheral blood. The same gating scheme was applied to CD4+ cells. (B) Dot plots of CD8+ cells from representative healthy donor across indicated fluorescence-minus-one (FMO) controls, used in the setting of gates.
No takes yet. Share an insight, caveat, or question.
Goswami et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: